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Given the high degree of psychosocial problems in patients with lung cancer, quality medical
care would benefit from exploring and addressing and providing potential solutions for these
problems.
Patients with recently diagnosed non-small-cell lung cancer filled out a questionnaire that
assessed illness perceptions and made a drawing of how they perceived their diseased lungs
look. They also participated in an interview about the impact of lung cancer in their lives.
Scores on the Brief Illness Perception Questionnaire indicated that patients score low on
‘concern’, ‘emotional response’ and ‘timeline’, indicating they hope to be cured from lung
cancer. Patients drew the tumor larger than it is on the chest radiograph. The drawings are
moderately accurate representations of the patients’ lungs. In the interviews patients often
expressed their hopes of being cured and how thinking positively would help. Patients who
made a more accurate drawing of their lungs had less optimistic views about their prognosis.
These views are more in line with the prognosis their physician would give them. However, few
patients made an accurate drawing.
This study contributes to a better insight into what patients believe and feel about their
disease. Suggestions for taking patient perceptions into account are provided.
ª 2012 Elsevier Ltd. All rights reserved.10838564; fax: þ31 71 524 8123.
ail.leidenuniv.nl (M.A. Hoogerwerf).
2 Elsevier Ltd. All rights reserved.
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Cancer is a highly disruptive disease with great impact on
patients’ lives. Due to the relatively poor prognosis and the
invasive and disruptive treatment, patients with lung cancer
report higher levels of distress than patientswith other types
of cancer.1 They report a high number of unmet needs in
psychosocial care and high levels of anxiety and depression.2
Research shows how attention to psychosocial needs can
diminish symptoms and anxiety.3,4 Because the incidence
and mortality from lung cancer remain high5,6 and curative
treatment is not available in many cases, quality of life is
extra important in treating patients with lung cancer.
For medical professionals, realising how patients expe-
rience their disease may be instrumental in giving the best
possible care. One way to examine the beliefs of patients
about their illness is through investigating illness percep-
tions. In the Self-Regulation Model, Leventhal et al.7
describe that in response to a health threat, patients
form perceptions about that perceived threat. Patients will
also form a coping plan to deal with the consequences of
the health threat or illness.8 The illness perceptions can be
divided into two categories: cognitive and emotional, with
the following dimensions: consequences (the influence on
the patient’s life), timeline (how long the illness will last),
control (both personal and treatment control), identity (the
complaints attributed to the illness), concern, coherence
(can the patient make sense of the illness), emotional
response, and cause. Illness perceptions drive coping,
illness behaviour and, therefore, outcome of medical and
psychosocial care.9,10 It is crucial to note that illness
perceptions are most likely to be not ‘objectively’ correct.
Leaving aside the issue of what ‘medically correct’ is,
illness perceptions reflect the emotional and cognitive
response of people to a complaint, a symptom, or an
illness. People are motivated to act by these ‘subjective’
representations of what is happening in their body, and
what medical management does to it. This offers a chance
to influence adherence, self-management and outcome via
studying and addressing these illness perceptions.11e13
Hirsch et al.14 and Lutgendorf and Sood.15 have also
demonstrated how illness perceptions and psychological
influences impact health outcomes in patients with cancer,
thereby underlining the importance of integrating patients’
subjective views into standard clinical care.
Illness perceptions can be assessed with questionnaires
(e.g. B-IPQ, IPQ-R) or open interviews. Illness perceptions
can also be identified in patient’s stories, for instance
through weblogs or personal accounts written by patients or
family, and in novels (for example Julia Glass e Three
Junes, Alice Elliot Dark e Watch the animals). A third and
relatively new way of assessing illness perceptions is the
use of drawings. Reynolds et al. have demonstrated that
drawings made by patients after a myocardial infarction are
good predictors of their physical and psychological status
afterwards16 Similar results have been found in patients
with headaches, vestibular schwannoma and SLE.17e19
There have been several earlier studies into illness
perceptions in lung cancer patients. Kaptein et al. have
compared illness perceptions and quality of life in Dutch and
Japanese patients.8 Other studies have focused on smokingbehaviour and cause attribution.20,21 Several studies have
used qualitative interview techniques to identify important
themes after a diagnosis of lung cancer.22,23 This study is the
first to use drawings to investigate illness perceptions in lung
cancer patients. Also, it is the first study to combine draw-
ings, an illness perceptions questionnaire and interviews in
a sample of patients with non-small-cell lung cancer. Given
the paucity of research about illness perceptions in patients
with lung cancer, this study is exploratory in its nature. It
investigates (a) the illness perceptions patients with lung
cancer hold, (b) the associations between these perceptions
and scores on a validated measure that assesses illness
perceptions (B-IPQ), and (c) the associations between illness
perceptions as reflected in drawings and B-IPQ scores, and
the chest X-ray which depicts the tumour.Patients and methods
Patients were recruited from the out-patient clinic of the
department of Respiratory Medicine of the Leiden Univer-
sity Medical Center. Included were patients with non-small-
cell lung cancer (NSCLC), any stage, who spoke sufficient
Dutch or English to complete the interview, were physically
well enough to sustain the interview, who had had at least
one appointment with a treating physician after the diag-
nosis was made, and who were receiving or were going to
receive some form of treatment. Patients were excluded if
they had a medical education. Written informed consent
was obtained from all patients. Tumor stage, pathology and
the chest radiograph at time of diagnosis were obtained
from the medical files after patients’ written consent.
At the start of the interview, information about marital
status, level of education and smoking status was
collected. Patients were then asked to make a drawing of
what they imagined their diseased lungs look like. They
were also asked to fill out the Brief Illness Perception
Questionnaire (B-IPQ). This is a questionnaire consisting of
8 questions measuring 8 dimensions of illness perceptions
on a scale from 0 to 10, and an open question about what
the patient considers to be the causes of the illness.24 To
gain a more detailed picture, the researcher asked the
patients to explain their answers. Patients’ answers were
tagged down in keywords. These keywords were later cat-
egorised and counted. Afterwards, patients were invited to
discuss further issues that had not previously been dis-
cussed but that they felt to be important too.
The drawings were analysed using ImageJ software.25 The
size of the tumorwasmeasured and the proportions between
tumor and lung were calculated. Measurements were done
by two assessors. Agreement between measurements was
assessed with a Bland Altman plot. Measurements that did
not fit within  2SD were discussed and consensus was
reached between the assessors. In the chest radiographs, the
size of the tumor and the lungweremeasured using the same
procedure.
The drawings were analysed by defining three categories of
importance: correctness of the shape of the lung, size of the
tumor, and level of detail. These aspects were subsequently
scored by each researcher individually as high or low for level
of detail, correct or incorrect for shape of the lungs, and
1172 M.A. Hoogerwerf et al.location of the tumor. The researchers were three of the four
authors of this article: a medical student, a pulmonary
physician and a psychologist specialised in illness perceptions.
This choice of researcher ensured that the drawings were
assessed regarding both the clinical andpsychological aspects.
The kappa value for inter-observer reliability was 0.553.
The scores of the three researchers were averaged to
create one score for each category.
The mean scores on the B-IPQ were calculated. The expla-
nations given by the patients were categorised and scored.
Descriptive statistics were performed for the patient
characteristics. Correlation between outcomes was
assessed with Spearman’s rank correlation coefficient. All
calculations were done using PASW SPSS version 18.
The research project was approved by the Medical Ethics
Committee of the Leiden University Medical Center.
Results
Twelve patients were included. Patient characteristics are
given in Table 1.
Drawings
One patient was not able to make the drawing. She was
feeling unwell during the interview and could not sit up
straight to complete a drawing. She did complete the
questionnaire and interview. Three drawings were rated asTable 1 Patient characteristics.
Characteristic Patients (n Z 12)
Gender
Male 5
Female 7
Age (years)
Median (range) 70 (52e88)
Histology
Squamous 7
Adeno 4
Large cell 1
Stage
I 2
III 3
IV 7
Treatment modality
Surgery 3
Hemotherapy 11
Radiation therapy 7
Smoking status
Current smoker 3
Former smoker 8
Never smoked 1
Years smoked
Median (range) 30 (0e66)
Education
Primary school 2
Vocational training 5
Secondary education 3
Higher education 2high in detail, 8 as low. Location of the tumor was judged to
be correct in 4 drawings, shape was rated as correct in 5.
The interval between observing the chest X-ray and making
the drawing was found not to have an effect on the accu-
racy and level of detail of the drawing.
The drawings of the diseased lung measured on average
19.03 cm2 (range 5.42e53.58). The mean percentage of
space within the lung drawing taken by the tumor was
10.98% (0.55e28.24). The mean percentage of the tumor on
the chest radiograph was 5.91% (0.63e15.30). The mean
ratio between these two measurements was 2.37
(0.52e9.95). Six patients drew the tumor over twice the
size it is on the chest X-ray.
Three patients’ drawings and their chest X-rays are
included (see Fig. 1). Illustration 1A shows the drawing and
chest radiograph of a 76-year old retired plumber who
wanted to know everything about his illness. He had looked
very carefully at his chest X-ray and made a very accurate
drawing, depicting his lungs before and after treatment.
Illustration 1B shows the drawings and chest X-ray of a 58-
year old engineer. He has drawn the tumors in his lungs and
the metastasis in his head. Illustration 1C shows the
drawing of a 74-year old lady. The tumor is in the same
location as in the lateral chest radiograph, but the drawing
is made as seen from the front.
B-IPQ
The average scores on the B-IPQ dimensions are displayed
in Table 2. Most scores are moderate, between 5 and 7.
Treatment control scores highest (7.50). Scores around 5 on
‘emotional response’ and ‘concern’ indicate that patients
are not highly emotional or worried. Scores on the B-IPQ
dimensions for melanoma, diabetes type 2, SLE and in
a previous study in lung cancer patients are included in the
table.7,23,26 Patients in this study answered lower on
‘concern’ and higher on ‘personal control’ than in
a previous study in patients with NSCLC. Patients with
diabetes type 2 or SLE score higher on timeline. Coherence
is significantly higher in melanoma patients and identity is
lower. Most named causes for lung carcinoma were smoking
(nZ 6) and bad luck (nZ 4). Other causes mentioned were
hard work, stress, genes and familiar disposition, nutrition
and working with chemicals. Two patients said that they
had “no idea” what caused their disease.
Interview
The explanations given during the interview are categorised
in Table 3. Of the 12 patients, four patients answered they
cannot be cured and will die of their disease, whereas four
clearly expressed their hope to be cured. Most patients are
convinced that being positive helps in being cured or doing
better during chemotherapy. Only one patient answered
that he knew the treatment would not cure him. In half of
the patients, their physical complaints were caused mainly
by the chemotherapy, according to the patients. Four
patients said they were not worried about the disease. “I’m
not worried. I’ll worry when I have to. Keeping positive is
better for my peace of mind.” Those who were concerned
worried about letting go of their family or the pain their
Figure 1 Left: X-thorax, made before treatment Right: Patient drawing Illustration 1A: Patient drawing left: 1e opname Z first
admission, licht grijsZ light grey Patient drawing right: hersteldZ recovered, 4eZ after fourth chemo, donker grijsZ dark grey.
Illness perceptions in lung cancer patients 1173family experienced, and about how the disease would
develop and what would happen to them. “I’m not worried
about me, when I die everything is taken care of. I do worry
about letting go of my family, of my wife. I would have loved
to grow old together”. Patients often wondered ‘why me?’
Often, they did not understand why this happened to them.
“Of course I don’t understand. Who can understand bad
luck?”When asked for other things patients found important
to discuss, most mentioned the health care system. Gener-
ally, they thought the medical staff was very friendly. The
patients would like their physician to have more attention
for the psychological and social consequences and their fears
and to understand that waiting can be very tormenting.
“Waiting in the waiting room is killing, especially when the
doctor is running late.” They also mentioned that lung
cancer seemed worse than other types of cancer, because of
the unfavourable prognosis and the association withTable 2 Scores on the B-IPQ dimensions (means and standard d
are computed with current sample (n Z 12) as reference sample
B-IPQ dimension Mean  SD
Lung cancer N Z 12 Lung cancer17 N Z
Consequences 6.67  2.61 7.50  2.86
Timeline 7.17  2.41 6.13  2.70
Personal control 6.50  1.93 3.88  3.60*
Treatment control 7.50  1.88 6.82  2.59
Identity 5.92  2.61 3.70  3.05
Concern 5.50  2.91 7.83  2.63*
Coherence 5.33  3.75 5.58  3.45
Emotional response 4.67  2.74 5.21  3.09
*p < 0.05.smoking. “Lung cancer is worse than for instance bowel
cancer. You could have prevented this.”Associations between B-IPQ, drawings and
interview
Because of the small sample size, statistical analyses are
limited to a few correlations.
There is a statistically significant correlation between
the accuracy of the drawing and the answer to the B-IPQ
dimension ‘timeline’: the higher the score on timeline, the
higher the accuracy of the drawing. Also, patients with
a more accurate drawing expressed less hope of being
cured by the treatment. This illustrates that patients with
a more accurate drawings were less optimistic about their
chances of being cured from the disease.eviations), compared with other patient samples. Differences
.
24 Melanoma27 N Z 120 DM211 N Z 119 SLE10 N Z 32
4.74  3.00* 4.7  2.9* 6.5  2.3
5.78  3.56 9.2  1.9* 9.2  1.8*
6.61  2.79 6.7  2.3 5.6  2.7
7.93  2.12 8.0  2.3 8.4  1.6
2.23  2.62* 4.6  2.8 6.0  2.6
5.42  3.21 7.0  3.1 5.8  2.7
8.08  2.21* 7.9  2.3* 6.8  2.6
4.37  2.91 4.3  3.3 5.8  2.7
Table 3 Patient interview.
Dimension Answers (no. of patients)
Consequences Restrictions7
Letting go of family
No future anymore
Making last arrangements
Betrayed by body
Positive consequence: attention
of family and friends2
Timeline Cannot be cured4
Hope to be cured4
The doctor’s says I’ve got this
much chance2
The disease can bloom every moment2
No idea2
Personal control Positive attitude helps8
Can do little yourself 3
Treatment control I noticed or saw on the x-rays
that treatment helps6
I hope it helps this much3
Won’t cure me
Identity Complaints mostly due to treatment6
Fatigue5
Shortness of breath3
Difficulties while walking3
Pain3
Coughing2
None2
Difficulty sleeping
Nausea
Concern Letting go of family, worries
about family4
Don’t worry4
What will happen to me2
There is no cure
You have to put faith in what
doctors do
Coherence Don’t understand why this happened
to me, why me?6
I want to know everything2
Just happens to you, nothing to
be understood
It’s a mysterious illness
Emotional
response
Just happens, go on as usual5
Fear4
Sadness2
Anger2
Keeping busy helps2
Other Very friendly medical staff5
Worse than other types of cancer,
brought this on yourself3
Waiting for treatment or appointments
with the doctor is very hard3
Important that doctors explain things
and are open to patients3
Doctor only interested in medical
issues, would like to talk about
non-medical issues2
Difficult the GP left this so long
I feel like a number in hospital
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there is a connection between size of the drawing and
worries. Patients with larger drawings of the tumour
generally commented that they were more worried and felt
that their disease would last longer.DiscussionMajor findings
This study illustrates the beliefs of patients with lung
cancer and the degree of accuracy of their views on the
tumor in their lungs.
The patient drawings are moderately accurate. There
are large differences between patients: some draw an
almost perfect copy of the chest radiograph whereas some
drawings are far removed from the actual situation. In six
out of eleven drawings, the tumor is drawn twice the size it
is on the chest X-ray. This could be due to the assignment of
drawing the lungs as imagined with the tumor in it. It could
also show that patients tend to ‘blow up’ the tumor in their
head because of the very substantial influence it has on
their lives. In patients with heart failure a larger drawing of
the heart was associated with higher levels of heart-specific
anxiety.16 In our study, patients who drew a large tumor
appeared to be more worried and answered that their
disease would last longer or their entire life. At the time of
diagnosis, patients were shown their chest radiograph and
their physician made a drawing for them as well. Some
patients had seen repeated control chest radiograph. The
interval between seeing the chest X-ray and making the
drawing varied between three months and one week. There
was no relation between the duration of the interval and
the accuracy of the drawing. Most drawings are not
consistent with the chest radiograph or the doctor’s view,
reflected in the scores on location of the tumor and shape
of the lungs.
There are several surprising outcomes in the B-IPQ
scores. The score on ‘concern’ is relatively low. Lung
cancer is a very serious disease with an unfavourable
prognosis. Patients would be expected to worry a lot. The
same goes for the score on emotional response. Further-
more, patients score their illness as lasting 7.17 out of 10.
This score is significant, because the highest score is ‘this
disease will last the rest of my life’. Patients who gave this
answer acknowledged that they would die from lung
cancer. Patients who gave answers lower on the scale
hoped they would eventually be cured or did not dare to
face that they would die from lung cancer. Denial could
influence these outcomes: patients may well know how
serious their illness is but may be afraid to admit this.
In this study, there was no evidence that patient’s
perceptions influenced their treatment trajectory or self-
care. Patients with unrealistic optimistic expectations did
not express less willingness to be treated or worse self-
care. On the contrary, it appears from the interviews that
patients who have more hopes to be cured, also have more
faith in the treatment, because they expect it will cure
them. However, this was not systematically studied and can
only be concluded based on impressions from the interview.
Illness perceptions in lung cancer patients 1175Patients with more accurate drawings were less opti-
mistic about their disease and had a perception of their
illness and prognosis that is more like that of their physi-
cian. Most oncologists and pulmonologists would acknowl-
edge that is it very likely that the patients will die from
their disease. The 5-year survival rate of lung cancer is 50%
for stage IA and drops to 2% for stage IV.27 This is not in line
with what patients hope for: many express their hopes that
they will be cured, even though they have been diagnosed
with stage III or IV NSCLC. This mechanism has been
described by Salander et al. (1999) as ‘disavowal’: self-
deception in the face of an accurate perception, as a way
to cope with their diagnosis and treatment.28 This can also
be brought about by doctors: The described in her thesis
how patients can hold on to the smallest hope in the
expressions of their physicians.29
Comparison with the literature
Other studies have found the same effect of denying the
severity of the illness or denying smoking as a cause for lung
cancer.20,29 Bertero¨ et al. described that patients generally
want to go on as usual and adapt themselves to be able to
do this.21 The patients in our study also frequently
mentioned they want to go on as usual. They find that the
physical restrictions influence their lives the most and they
do not want to let the disease affect them too much
emotionally. That would interfere with going on as usual.
The B-IPQ has been used in a previous study in NSCLC
patients.8 This earlier study showed a lower score on
‘personal control’ and a higher score on ‘concern’
compared with the current sample. The patients in our
study were interviewed earlier in the disease process. The
score on ‘personal control’ has been shown to decrease in
time after diagnosis.21 The comparison between B-IPQ
scores shows that lung cancer is not perceived as
a chronic disease like SLE or diabetes mellitus. Patients
said they would either die from the disease or be cured.
For both melanoma and lung cancer an important causal
factor is known, but patients with melanoma report
a higher coherence. This is consistent with the remarks of
the lung cancer patients about lung cancer as a ‘myste-
rious illness’ and ‘worse than other types of cancer’.
Melanoma is also more visible than lung cancer, which
may make it less of a mystery. Furthermore, lung cancer is
often discovered in a more advanced stage which may
influence coherence.
Limitations
Because of the small number of patients, this study cannot
assess the values of the drawings accurately. There are
some associations found, but statistics are not completely
reliable in such a small study. In order to assess the value of
drawings more accurately, studies in larger patient groups
are needed. Furthermore, the outcomes may be biased
through selection bias. Those patients who did not want to
talk about their illness may experience more concern and
emotional effects of the disease which makes them
unwilling to talk about it. Also, patients who were severely
ill appeared to be less willing to participate in the study,which may have caused a selection bias towards healthier
patients.
Age could have been a confounder in this study, as
elderly patients could have resigned more easily to their
disease and would therefore have been less concerned.
However, the level of concern was not observed to have any
relation with age and was spread randomly between the
ages.Research implications and clinical implications
Although this is a pilot study, several important features are
found. This warrants research in a larger group of patients
in order to validate these findings. Furthermore, it is clin-
ically very relevant to know how patients’ perceptions
influence their treatment trajectory and self-care. This was
not systematically addressed in this study. Drawings have
shown to be a good way of researching illness perceptions.
They can hold valuable information about how the patients
feel about their illness. If more research is done into
drawings and their meaning, they might be a valuable
addition to clinical practice.
Patients’ illness perceptions are not always in line with
what their physician thinks. This may be a reflection of
patients’ coping styles or a lack of understanding between
doctor and patient. It is important to address these
differences in order to provide the best possible care,
because illness perceptions influence illness behaviour
and expectations. Patients should hold realistic views of
their prognosis to be prepared for what might come. On
the other hand, hope is very important for patients to
sustain the diagnosis and the demanding treatment.30 It is
the physician’s task to navigate between these two ends
and to find the right balance for each patient between
keeping up patients’ spirits but also correcting views that
are simply wrong. Denial has been shown to have
a protective effect on psychological and social outcomes
in patients,31 but isn’t it important for patients to know
what is coming to them? This question is vital in care for
patients with lung cancer. In other diseases, there has
been extensive research into how to influence patient
perceptions to obtain the best outcomes. Skinner et al.
have investigated the influence of illness representations
on clinical outcomes13 and Petrie et al. have initiated the
first studies how changing illness perceptions can change
patient outcomes in patients with asthma and myocardial
infarction.32,33 That kind of research is needed in lung
cancer patients too. Furthermore, in this study, patients
expressed they would like their physician to pay more
attention to their psychosocial issues. The questions of the
B-IPQ and the production of a drawing can be a useful tool
in doing so. Furthermore, early palliative care has shown
to improve quality of life and survival in lung cancer
patients.34 These findings emphasise the importance of
a complete treatment with attention to biomedical,
palliative and psychological care.Conflict of interest statement
None declared.
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